High-Throughput Cysteine Scanning To Identify Stable Antibody Conjugation Sites for Maleimide- and Disulfide-Based Linkers
Conjugate
Disulfide Linkage
Succinimides
Maleimide
DOI:
10.1021/acs.bioconjchem.7b00791
Publication Date:
2018-02-09T19:42:23Z
AUTHORS (20)
ABSTRACT
THIOMAB antibody technology utilizes cysteine residues engineered onto an to allow for site-specific conjugation. The has enabled the exploration of different attachment sites on in combination with small molecules, peptides, or proteins yield conjugates unique properties. As reported previously ( Shen , B. Q. et al. 2012 ) Nat. Biotechnol. 30 184 - 189 ; Pillow T. H. 2017 Chem. Sci. 8 366 370 ), specific location site conjugation can impact stability linkage both thio-succinimide and disulfide bonds. High is usually desired maximize delivery cargo intended target. In current study, cysteines were individually substituted into every position anti-HER2 (trastuzumab), stabilities drug conjugations at those evaluated. We screened a total 648 antibody-drug conjugates, each generated from trastuzamab prepared by sequentially mutating non-cysteine amino acids light heavy chains cysteine. Each variant was conjugated either maleimidocaproyl-valine-citrulline-p-aminobenzyloxycarbonyl-monomethyl auristatin E (MC-vc-PAB-MMAE) pyridyl monomethyl (PDS-MMAE) using high-throughput, on-bead purification method. Greater than 50% variants successfully MMAE derivatives ratio (DAR) >0.5 <50% aggregation. relative vitro plasma approximately 750 assessed enzyme-linked immunosorbent assays, stable confirmed affinity-capture LC/MS-based detection methods. Highly two types identified chains. Although maleimide shown be greater many that both. Furthermore, selected translated across cytotoxic payloads target antibodies as well vivo stability.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (37)
CITATIONS (93)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....